Tarsus Pharmaceuticals
TARS
TARS
203 hedge funds and large institutions have $1.87B invested in Tarsus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 85 increasing their positions, 50 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+12
Holders Change %
+6.28%
% of All Funds
2.72%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.05%
New
44
Increased
85
Reduced
50
Closed
29
Calls
$417K
Puts
–
Net Calls
+$417K
Net Calls Change
-$347K
Top Buyers
Top Sellers
| 1 |
1
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
$40.6M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$9.29M |
| 3 |
O
3
OrbiMed
New York
|
$8.02M |
| 4 |
GGHC
4
Gilder Gagnon Howe & Co
New York
|
$3.13M |
| 5 |
5
Lord, Abbett & Co
Jersey City,
New Jersey
|
$40.3M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OC
226
Oppenheimer & Co
New York
| – | -$211K | -4,100 | Closed |
|
|
BAMF
227
BI Asset Management Fondsmaeglerselskab
Kobenhavn,
Denmark
| – | -$30K | -579 | Closed |
|
|
QCG
228
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$4.57K | -89 | Closed |
|
|
BIG
229
Brooklyn Investment Group
Brooklyn,
New York
| – | -$925 | -18 | Closed |
|
|
CCM
230
Coldstream Capital Management
Bellevue,
Washington
| – | -$616 | -12 | Closed |
|
231
Amundi
Paris,
France
| – | -$496 | -10 | Closed |
|
|
SC
232
Stephens Consulting
Flint,
Michigan
| – | -$514 | -10 | Closed |
|